Reproductive Health

News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.

The company is now seeking commercial partners in Brazil to make the Iona test available in the country.

The goal is to generate clinical outcome and economic data that will make the case to payors to cover NIPT for average-risk pregnancies.

A jury agreed that Ariosa's noninvasive prenatal test infringed several claims in two patents held by Illumina.

Adam Wolfberg argued that while corporate conflicts are widely discussed, physicians also have financial conflicts that can bias them against new technology.

The two companies intend to develop and commercialize several cancer and NIPT assays using a combination of their technologies.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.